Product Information
GLYCOPYRROLATE 0.2 MG/ML VIAL is a generic product labeled by Athenex Pharmaceutical Division, LLC., priced at $1.5137 per ML under NDC 70860078101. Its NADAC has been published 63 times since Dec 18, 2024.
FDA first approved this application on Feb 21, 2020. Its Orange Book therapeutic-equivalence code is AP.
Strength
.2 mg/mL
Manufacturer
Athenex Pharmaceutical Division, LLC.NDC
70860078101
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS
Effective Date
8/20/2025
Active Ingredients
GLYCOPYRROLATEApproval Type
Generic (ANDA)
FDA Application
ANDA210083FDA Approved
2/21/2020
TE Code
AP
On Market Since
1/31/2023
Pharmacological Classes
Price Statistics
The NADAC for GLYCOPYRROLATE 0.2 MG/ML VIAL has been published 63 times since Dec 18, 2024, and over the history we have for it it has risen 8.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.5137 per ML |
|---|---|
| All-time high | $1.5856 (Aug 13, 2025) |
| All-time low | $1.3976 (Dec 18, 2024) |
| 52-week high | $1.5137 |
| 52-week low | $1.5137 |
| Median price | $1.5137 |
| Average price | $1.4972 |
| Largest weekly change | +5.6% (Jan 22, 2025) |
| Weeks tracked | 63 |
| Tracking since | Dec 18, 2024 |
1W
N/A
1M
N/A
3M
N/A
6M
0.0%
1Y
0.0%
3Y
N/A
5Y
N/A
All
+8.3%
Last surveyed Feb 25, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of GLYCOPYRROLATE 0.2 MG/ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for GLYCOPYRROLATE 0.2 MG/ML VIAL, manufactured by Athenex Pharmaceutical Division, LLC., is $1.5137 per ML (NDC 70860078101), effective Feb 25, 2026.
How has the price of GLYCOPYRROLATE 0.2 MG/ML VIAL changed over time?
Over the history we have for it, the NADAC for GLYCOPYRROLATE 0.2 MG/ML VIAL has risen 8.3%. It has been tracked across 63 weekly CMS publications since Dec 18, 2024.
What are the highest and lowest recorded NADAC prices for GLYCOPYRROLATE 0.2 MG/ML VIAL?
Since Dec 18, 2024, the NADAC for GLYCOPYRROLATE 0.2 MG/ML VIAL has ranged from a low of $1.3976 (Dec 18, 2024) to a high of $1.5856 (Aug 13, 2025), with a median of $1.5137 per ML.
Are there cheaper alternatives to GLYCOPYRROLATE 0.2 MG/ML VIAL?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, GLYCOPYRROLATE 0.2 MG/ML VIAL, is $1.4806 per ML — about 2% below GLYCOPYRROLATE 0.2 MG/ML VIAL.
Who manufactures GLYCOPYRROLATE 0.2 MG/ML VIAL?
GLYCOPYRROLATE 0.2 MG/ML VIAL (NDC 70860078101) is labeled by Athenex Pharmaceutical Division, LLC., and CMS classifies it as a generic product.